A549 cells infected with RSV Analysis Results (GEO series: GSE147507)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
HIC1 | hg19_v2_chr17_+_1959369_1959604 | 0.59 | 4.1e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr3_-_45267760 Show fit | 0.81 |
ENST00000503771.1
|
transmembrane protein 158 (gene/pseudogene) |
|
chr1_+_23037323 Show fit | 0.66 |
ENST00000544305.1
ENST00000374630.3 ENST00000400191.3 ENST00000374632.3 |
EPH receptor B2 |
|
chr19_+_35521699 Show fit | 0.58 |
ENST00000415950.3
|
sodium channel, voltage-gated, type I, beta subunit |
|
chr19_+_35521572 Show fit | 0.56 |
ENST00000262631.5
|
sodium channel, voltage-gated, type I, beta subunit |
|
chr16_+_56642489 Show fit | 0.55 |
ENST00000561491.1
|
metallothionein 2A |
|
chr12_-_132905789 Show fit | 0.51 |
ENST00000328957.8
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) |
|
chr6_-_160114260 Show fit | 0.48 |
ENST00000367054.2
ENST00000367055.4 ENST00000444946.2 ENST00000452684.2 |
superoxide dismutase 2, mitochondrial |
|
chr2_-_7005785 Show fit | 0.46 |
ENST00000256722.5
ENST00000404168.1 ENST00000458098.1 |
cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial |
|
chrX_-_153151586 Show fit | 0.45 |
ENST00000370060.1
ENST00000370055.1 ENST00000420165.1 |
L1 cell adhesion molecule |
|
chr18_+_77439775 Show fit | 0.44 |
ENST00000299543.7
ENST00000075430.7 |
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) phosphatase, subunit 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.5 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
0.2 | 0.7 | GO:0051389 | inactivation of MAPKK activity(GO:0051389) |
0.1 | 0.7 | GO:0003070 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
0.1 | 0.7 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.0 | 0.7 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.2 | 0.6 | GO:0071629 | cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071629) |
0.1 | 0.6 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
0.1 | 0.5 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 0.5 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.0 | 0.5 | GO:0009299 | mRNA transcription(GO:0009299) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.5 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.0 | 0.9 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 0.8 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 0.6 | GO:0032059 | muscle thin filament tropomyosin(GO:0005862) bleb(GO:0032059) |
0.0 | 0.6 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.6 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 0.5 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 0.4 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.0 | 0.4 | GO:0032437 | cuticular plate(GO:0032437) |
0.0 | 0.4 | GO:0005587 | collagen type IV trimer(GO:0005587) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.5 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
0.1 | 1.0 | GO:0030957 | Tat protein binding(GO:0030957) |
0.0 | 0.9 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 0.7 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 0.7 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.0 | 0.6 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.1 | 0.5 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.0 | 0.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.5 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.1 | 0.4 | GO:1990699 | palmitoleyl hydrolase activity(GO:1990699) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.9 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.9 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.9 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.8 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.7 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.5 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.2 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 1.1 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 1.0 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.7 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.0 | 0.6 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.4 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.4 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.4 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.4 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.4 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |